HPV Prevalence in Transpersons - a Prospective Study

NACompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

May 2, 2021

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions
Papillomavirus InfectionTranssexualism
Interventions
DIAGNOSTIC_TEST

Colli-Pee urine collection device

first-void urine is collected using Colli-Pee and subsequently analyzed using Anyplex™ II HPV HR Detection from Seegene.

OTHER

Survey

Subjects are asked to complete a survey that includes questions about sexual orientation, hormone therapy, gender reassignment surgery, number of sexual partners, HPV vaccination, and smoking

Trial Locations (2)

1000

Institute of Microbiology and Immunology Faculty of Medicine, Ljubljana

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Sophie Pils

OTHER